Login to Your Account

Last minute gift from the FDA: Nusinersen wins approval in SMA

By Jennifer Boggs
Managing Editor

Tuesday, December 27, 2016

Biogen Inc. plans to make newly approved SMA drug Spinraza (nusinersen) available within a week of its FDA nod late Friday, marking the first drug indicated for SMA.

To continue reading subscribe now to Latest News

Learn More about Latest News

Already a subscriber? Sign In or Buy now to activate your subscription